^
    Contact us  to learn more about
    our Premium Content:  News alerts, weekly reports and conference planners

    TEST:
    VENTANA® Kappa and Lambda Dual ISH mRNA Probe Cocktail Assay

    Company:
    Roche
    Type:
    CE Marked
    Related tests:
    Details
    Evidence

    News

    8d
    An Ultrasensitive Kappa and Lambda (K/L) Dual in-Situ Hybridization (ISH) mRNA Assay for Light Chain Restriction Offers Pre-analytical Flexibility (AMP 2024)
    In this study, 3 pre-analytical components were assessed for the VENTANA Kappa and Lambda Dual ISH mRNA Probe Cocktail Assay. There are many acceptable tissue thickness, fixation, and decalcification options that are compatible with this assay.
    VENTANA HER2 Dual ISH DNA Probe Cocktail • VENTANA® Kappa and Lambda Dual ISH mRNA Probe Cocktail Assay
    5ms
    Roche launches new highly-sensitive test to more easily diagnose patients who may have B-cell lymphoma (Roche Press Release)
    "Roche...launch of the first clinically approved, highly-sensitive in-situ hybridisation (ISH) test, the VENTANA® Kappa and Lambda Dual ISH mRNA Probe Cocktail assay, in countries accepting the CE Mark. The test is designed to help pathologists differentiate a B-cell malignancy from a normal, reactive response to an infection."
    Launch Europe • Approval
    |
    VENTANA® Kappa and Lambda Dual ISH mRNA Probe Cocktail Assay